IMU 2.08% 4.9¢ imugene limited

Media Thread, page-6382

  1. 2,313 Posts.
    lightbulb Created with Sketch. 647

    Done!
    I nominated Leslie for the following ......


    PD1-Vaxx , a B-cell immunotherapy, has promising results even at Phase1. Since first dosing on 1/12/2020 for late stage NSCL patients, at least one patient is still living with zero cancer burden (CR), and several other patients have PR and SD !

    @edski1. Thanks for doing it again this year.

    kluck
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.